| Dr Christopher A Milburn, MD | |
|
3 Cooper Plz Rm 220, Camden, NJ 08103-1438 | |
| (856) 342-2000 | |
| Not Available |
| Full Name | Dr Christopher A Milburn |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 16 Years |
| Location | 3 Cooper Plz Rm 220, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609037985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | C1-0011454 (Delaware) | Secondary |
| 207RA0401X | Internal Medicine - Addiction Medicine | 25MA10217600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmc Department Of Medicine Group Pa | 2163335878 | 329 |
| Cmc Psychiatric Associates Pc | 2264401686 | 26 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Nearly two thirds of the states in the US saw a small decrease in mammography utilization between the years 2000 and 2006, according to a study performed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Nutrastar International Inc., a leading nutraceutical company which produces and distributes Chinese Golden Grass and organic and specialty food products in China, today announced its financial results for the first quarter 2010.
Novint Technologies, Inc. (OTCBB: NVNT) today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) subcontract to develop a videogame that will improve cognitive, motor, and sensory performance in soldiers suffering from traumatic brain injury (TBI). The SBIR was awarded by the Office of the Secretary of Defense (OSD) Defense Health Program.
› Verified 3 days ago
| Entity Name | Cmc Psychiatric Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982646634 PECOS PAC ID: 2264401686 Enrollment ID: O20041001000003 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Nearly two thirds of the states in the US saw a small decrease in mammography utilization between the years 2000 and 2006, according to a study performed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Nutrastar International Inc., a leading nutraceutical company which produces and distributes Chinese Golden Grass and organic and specialty food products in China, today announced its financial results for the first quarter 2010.
Novint Technologies, Inc. (OTCBB: NVNT) today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) subcontract to develop a videogame that will improve cognitive, motor, and sensory performance in soldiers suffering from traumatic brain injury (TBI). The SBIR was awarded by the Office of the Secretary of Defense (OSD) Defense Health Program.
› Verified 3 days ago
| Entity Name | Cmc Department Of Medicine Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386682094 PECOS PAC ID: 2163335878 Enrollment ID: O20050104000343 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Nearly two thirds of the states in the US saw a small decrease in mammography utilization between the years 2000 and 2006, according to a study performed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Nutrastar International Inc., a leading nutraceutical company which produces and distributes Chinese Golden Grass and organic and specialty food products in China, today announced its financial results for the first quarter 2010.
Novint Technologies, Inc. (OTCBB: NVNT) today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) subcontract to develop a videogame that will improve cognitive, motor, and sensory performance in soldiers suffering from traumatic brain injury (TBI). The SBIR was awarded by the Office of the Secretary of Defense (OSD) Defense Health Program.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher A Milburn, MD 1 Federal St # 100, Camden, NJ 08103-1088 Ph: (856) 356-4924 | Dr Christopher A Milburn, MD 3 Cooper Plz Rm 220, Camden, NJ 08103-1438 Ph: (856) 342-2000 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Nearly two thirds of the states in the US saw a small decrease in mammography utilization between the years 2000 and 2006, according to a study performed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.
Nutrastar International Inc., a leading nutraceutical company which produces and distributes Chinese Golden Grass and organic and specialty food products in China, today announced its financial results for the first quarter 2010.
Novint Technologies, Inc. (OTCBB: NVNT) today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) subcontract to develop a videogame that will improve cognitive, motor, and sensory performance in soldiers suffering from traumatic brain injury (TBI). The SBIR was awarded by the Office of the Secretary of Defense (OSD) Defense Health Program.
› Verified 3 days ago
Howard Isadore Kesselheim, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2 Cooper Plz, Camden, NJ 08103 Phone: 855-632-2667 | |
Richard Arthur Hellander, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 817 Federal St, Camden, NJ 08103 Phone: 856-583-2400 | |
Sivakoti Nagireddy Guda, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave Fl 6, Camden, NJ 08103 Phone: 856-757-3500 | |
Steven Mudroch Ii, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz Rm 513, Camden, NJ 08103 Phone: 856-963-3715 Fax: 856-635-1052 | |
Dr. Bradley Foster Bender, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-3150 | |
Dr. Amanda A Valvano, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Niku Thomas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2488 |